Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Extension Study for Participants in LIQ861 Trials to Evaluate the Long-term Safety of Dry Powder Inhalation of Treprostinil

ClinicalTrials.gov ID: NCT03992755

Public ClinicalTrials.gov record NCT03992755. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 6:01 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Global, Open-Label Extension Study for Participants in LIQ861 Trials to Evaluate the Long-term Safety of Inhaled LIQ861 (Treprostinil) in Pulmonary Arterial Hypertension (WHO Group 1) Patients

Study identification

NCT ID
NCT03992755
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Liquidia Technologies, Inc.
Industry
Enrollment
92 participants

Conditions and interventions

Interventions

  • LIQ861 Inhaled Treprostinil Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 17, 2019
Primary completion
May 30, 2025
Completion
May 30, 2025
Last update posted
Jan 28, 2025

2019 – 2025

United States locations

U.S. sites
25
U.S. states
16
U.S. cities
22
Facility City State ZIP Site status
Banner University Medical Center Phoenix Arizona 85006
Arizona Pulmonary Specialists, Ltd. Phoenix Arizona 85012
West Los Angeles VA Healthcare Center Los Angeles California 90073
UC Davis Medical Center Sacramento California 95817
Los Angeles Biomedical Research Center Torrance California 90502
University of Colorado Anschutz Medical Campus Aurora Colorado 80045
University of Florida Gainesville Florida 32610
Mayo Clinic-Jacksonville Jacksonville Florida 32224
AdventHealth Orlando Florida 32803
Emory University School of Medicine Atlanta Georgia 30322
Northwestern Medicine, Feinberg School of Medicine Chicago Illinois 60611
University of Chicago Medicine Chicago Illinois 60637
University of Kansas Medical Center Kansas City Kansas 66103
Ochsner Medical Center New Orleans Louisiana 70121
Tufts Medical Center Boston Massachusetts 02111
Mayo Clinic-Rochester Rochester Minnesota 55905
University of New Mexico Health Science Center Albuquerque New Mexico 87106
University of Cincinnati Medical Center Cincinnati Ohio 45267
Oregon Health and Science Center Portland Oregon 97239
Alleghany General Hospital Pittsburgh Pennsylvania 15212
UPMC Presbyterian Hospital Pittsburgh Pennsylvania 15213
UT Southwestern Medical Center Dallas Texas 75390
Houston Methodist Lung Center Houston Texas 77030
University of Texas Health Science Center at San Antonio San Antonio Texas 78229
INOVA Fairfax Medical Campus Falls Church Virginia 22042

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03992755, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 28, 2025 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03992755 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →